Naeem Yasir, Matsuo Bianca T, Davies Huw M L
Department of Chemistry, Emory University, Atlanta, Georgia 30322, United States.
ACS Catal. 2023 Dec 11;14(1):124-130. doi: 10.1021/acscatal.3c04661. eCollection 2024 Jan 5.
Catalyst-controlled C-H functionalization using donor/acceptor carbenes has been shown to be an efficient process capable of high levels of site control and stereocontrol. This study demonstrated that the scope of the donor/acceptor carbene C-H functionalization can be extended to systems where the acceptor group is a phosphonate. When using the optimized dirhodium catalyst, Rh(-(4-Br)TPPTTL), ((aryl)(diazo)methyl)phosphonates undergo highly enantioselective (84-99% ee) and site-selective (>30:1 r.r.) benzylic C-H functionalization. The phosphonate group is much more sterically demanding than the previously studied carboxylate ester group, leading to much higher selectivity for a primary site versus more sterically crowded positions. The effectiveness of this methodology has been demonstrated by the late-stage primary C-H functionalization of estrone, adapalene, ()-naproxen, clofibrate, and gemfibrozil derivatives.
使用给体/受体卡宾的催化剂控制的C-H官能化已被证明是一种高效的过程,能够实现高水平的位点控制和立体控制。本研究表明,给体/受体卡宾C-H官能化的范围可以扩展到受体基团为膦酸酯的体系。当使用优化的二铑催化剂Rh(-(4-Br)TPPTTL)时,((芳基)(重氮)甲基)膦酸酯会发生高度对映选择性(84-99% ee)和位点选择性(>30:1 r.r.)的苄基C-H官能化。膦酸酯基团在空间上的要求比先前研究的羧酸酯基团高得多,导致相对于空间位阻更大的位置,对伯位点具有更高的选择性。雌酮、阿达帕林、()-萘普生、氯贝丁酯和吉非贝齐衍生物的后期伯C-H官能化证明了该方法的有效性。